108 related articles for article (PubMed ID: 38196813)
1. Retraction of "lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells".
Liu Z; Hu K; Wang X; Zhang Y; Wang W; Wu Y
Open Med (Wars); 2023; 18(1):20230892. PubMed ID: 38196813
[TBL] [Abstract][Full Text] [Related]
2. lncRNA ACTA2-AS1 inhibits malignant phenotypes of gastric cancer cells.
Liu Z; Hu K; Wang X; Zhang Y; Wang W; Wu Y
Open Med (Wars); 2022; 17(1):266-279. PubMed ID: 35274046
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA ACTA2-AS1 Inhibits Cell Growth and Facilitates Apoptosis in Gastric Cancer by Binding with miR-6720-5p to Regulate ESRRB.
Hu Z; Chen Z; Jiang W; Fang D; Peng P; Yao S; Luo M; Wang L; Sun Z; Wang W; Wang X; Mao H; Ai F; Zhou P
Biochem Genet; 2023 Dec; 61(6):2672-2690. PubMed ID: 37222961
[TBL] [Abstract][Full Text] [Related]
4. lncRNA ACTA2-AS1 predicts malignancy and poor prognosis of triple-negative breast cancer and regulates tumor progression via modulating miR-532-5p.
Peng Y; Huang X; Wang H
BMC Mol Cell Biol; 2022 Jul; 23(1):34. PubMed ID: 35896973
[TBL] [Abstract][Full Text] [Related]
5. Retracted: Targeting the lncRNA FGD5-AS1/miR-497-5p/PD-L1 Axis Inhibits Malignant Phenotypes in Colon Cancer (CC).
International BR
Biomed Res Int; 2023; 2023():9864810. PubMed ID: 37829046
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA ACTA2-AS1 inhibits the cisplatin resistance of non-small cell lung cancer cells through inhibiting autophagy by suppressing TSC2.
Liu X; Zhang X; Du S
Cell Cycle; 2022 Feb; 21(4):368-378. PubMed ID: 34985374
[TBL] [Abstract][Full Text] [Related]
7. Mechanism underlying the regulation of lncRNA ACTA2-AS1 on CXCL2 by absorbing miRNA-532-5p as ceRNA in the development of ovarian cancer.
Li Y; Yang Z; Chen J
Int J Clin Exp Pathol; 2021; 14(5):596-607. PubMed ID: 34093945
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of lncRNA ACTA2-AS1 reverses cisplatin resistance of ovarian cancer cells via inhibition of miR-378a-3p-regulated Wnt5a.
Lin C; Zheng M; Yang Y; Chen Y; Zhang X; Zhu L; Zhang H
Bioengineered; 2022 Apr; 13(4):9829-9838. PubMed ID: 35412951
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of long non-coding RNA ACTA2-AS1 inhibits the viability, proliferation, migration and invasion of colorectal cancer cells.
Wu X; Pang Q; Zhi F; Mao X; Hu Y
Tissue Cell; 2022 Jun; 76():101769. PubMed ID: 35325674
[TBL] [Abstract][Full Text] [Related]
10. Retraction: LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation.
Frontiers Editorial Office
Front Oncol; 2021; 11():840152. PubMed ID: 35036360
[TBL] [Abstract][Full Text] [Related]
11. ACTA2-AS1 suppresses lung adenocarcinoma progression via sequestering miR-378a-3p and miR-4428 to elevate SOX7 expression.
Ying K; Wang L; Long G; Lian C; Chen Z; Lin W
Cell Biol Int; 2020 Dec; 44(12):2438-2449. PubMed ID: 32808728
[TBL] [Abstract][Full Text] [Related]
12. Retraction Notice to: lncRNA CEBPA-AS1 Overexpression Inhibits Proliferation and Migration and Stimulates Apoptosis of OS Cells via Notch Signaling.
Xia P; Gu R; Zhang W; Sun YF
Mol Ther Nucleic Acids; 2022 Sep; 29():75. PubMed ID: 35795480
[TBL] [Abstract][Full Text] [Related]
13. Retraction notice for: "lncRNA ZEB1-AS1 inhibits high glucose-induced EMT and fibrogenesis by regulating the miR-216a-5p/BMP7 axis in diabetic nephropathy" [https://doi.org/10.1590/1414-431X20209288].
Braz J Med Biol Res; 2023 May; 56():e9288retraction. PubMed ID: 37194836
[TBL] [Abstract][Full Text] [Related]
14. LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis [Retraction].
Onco Targets Ther; 2022; 15():681-682. PubMed ID: 35733651
[TBL] [Abstract][Full Text] [Related]
15. Retraction Notice to: Overexpressed lncRNA GATA6-AS1 Inhibits LNM and EMT via FZD4 through the Wnt/β-Catenin Signaling Pathway in GC.
Li ZT; Zhang X; Wang DW; Xu J; Kou KJ; Wang ZW; Yong G; Liang DS; Sun XY
Mol Ther Nucleic Acids; 2022 Jun; 28():594. PubMed ID: 35615007
[TBL] [Abstract][Full Text] [Related]
16. LncRNA ACTA2-AS1 suppress colon adenocarcinoma progression by sponging miR-4428 upregulation BCL2L11.
Pan Q; Huang Y; Wang Y; Li D; Lei C
Cancer Cell Int; 2021 Apr; 21(1):203. PubMed ID: 33845844
[TBL] [Abstract][Full Text] [Related]
17. Retraction Note: The carcinogenic complex lncRNA FOXP4-AS1/EZH2/LSD1 accelerates proliferation, migration and invasion of gastric cancer.
Chen RY; Ju Q; Feng LM; Yuan Q; Zhang L
Eur Rev Med Pharmacol Sci; 2022 Aug; 26(15):5311. PubMed ID: 35993622
[TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNA HAND2-AS1 Inhibits Growth and Migration of Gastric Cancer Cells Through Regulating the miR-590-3p/KCNT2 Axis [Retraction].
Onco Targets Ther; 2021; 14():4997-4998. PubMed ID: 34675541
[TBL] [Abstract][Full Text] [Related]
19. Retraction Notice to: lncRNA ILF3-AS1 promotes proliferation and metastasis of colorectal cancer cells by recruiting histone methylase EZH2.
Hong S; Li S; Bi M; Yu H; Yan Z; Liu T; Wang H
Mol Ther Nucleic Acids; 2023 Sep; 33():208. PubMed ID: 37727441
[TBL] [Abstract][Full Text] [Related]
20. Retraction: MiR-320d suppresses the progression of breast cancer
Shi S; Hu X; Xu J; Liu H; Zou L
RSC Adv; 2022 Sep; 12(41):26639. PubMed ID: 36275161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
